BMC / BIOTECHMETABOLISMCOMPOUNDS / INGREDIENT-LEVEL RESEARCH
EVIDENCE INDEX
A mechanism is not a clinical outcome. Ranges describe research, not suggested use. Formulations, elemental amounts and populations differ. This scale is a qualitative editorial overview, not a systematic review or product certification.
| Compound | Primary mechanism | Studied dose range | Evidence level |
|---|---|---|---|
| BMC-S01 Collagen Peptides | Peptides / extracellular matrix | 2.5–15 g | Moderate |
| BMC-S02 Collagen+ | Extracellular matrix / cofactors | Colágeno 2.5–15 g; HA 80–240 mg | Moderate |
| BMC-M01 NMN | NAD+ precursor | 250–1,000 mg | Emerging |
| BMC-M02 Creatine | Phosphocreatine / ATP system | 3–5 g | Robust |
| BMC-M03 Taurine | Osmoregulation / signaling | 1–6 g | Emerging |
| BMC-M04 Electrolytes | Fluid balance / neuromuscular function | Na 300–1,000 mg/h de ejercicio | Moderate |
| BMC-C01 Spermidine | Polyamines / autophagy signaling | 0.9–6 mg; formulaciones variables | Emerging |
| BMC-C02 GlyNAC | Glutathione precursors | Gly/NAC 1.2–3.6 g cada uno; variable | Emerging |
| BMC-C03 Omega-3 Ultra | Membrane lipids / signaling | EPA+DHA 1–3 g | Robust |
| BMC-C04 D3+K2 | Mineral metabolism / carboxylation | D3 600–2,000 IU; K2 90–180 μg | Moderate |
| BMC-N01 Mg L-Threonate | Enzyme cofactor / neurotransmission | Sal 1.5–2 g; Mg elemental variable | Emerging |
| BMC-N02 Lion’s Mane | Fungal compounds / neuronal signaling | 0.5–3 g; extractos no equivalentes | Emerging |
| BMC-N03 KSM-66 | Stress response / adaptation | 300–600 mg extracto estandarizado | Moderate |
Categories: human nutrition trials, pharmacokinetics, biochemical signaling, and exercise physiology. Ingredient evidence does not validate BMC combos. Consult a qualified professional before supplementation.